Bleeding Complications in Anticoagulated Patients With Atrial Fibrillation and Sepsis: A Propensity‐Weighted Cohort Study — Mette Søgaard (2017) | RDL Network
Bleeding Complications in Anticoagulated Patients With Atrial Fibrillation and Sepsis: A Propensity‐Weighted Cohort Study
Article 2017 en
Authors
MS
Mette Søgaard
FS
Flemming Skjøth
JK
Jette Nordstrøm Kjældgaard
Abstract
1 min read
AF patients who are on warfarin therapy at sepsis diagnosis experienced an increase in bleeding rates within the 3 months following sepsis. Warfarin use was associated with lower mortality, despite virtually comparable thromboembolic event rates.
Shinya Goto, Frank Cools, Freek W.A. Verheugt, Toon Wei Lim, Alexander G.G. Turpie, Martin van Eickels, Gloria Kayani, Giancarlo Agnelli, Pantep Angchaisuksiri, Barry Jacobson, Ajay K. Kakkar
Discussion(0)
No comments yet. Be the first to comment.